Laurent Rigoreau

2.3k total citations
23 papers, 1.4k citations indexed

About

Laurent Rigoreau is a scholar working on Molecular Biology, Organic Chemistry and Cell Biology. According to data from OpenAlex, Laurent Rigoreau has authored 23 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Organic Chemistry and 7 papers in Cell Biology. Recurrent topics in Laurent Rigoreau's work include Cancer therapeutics and mechanisms (9 papers), Bioactive Compounds and Antitumor Agents (5 papers) and DNA Repair Mechanisms (5 papers). Laurent Rigoreau is often cited by papers focused on Cancer therapeutics and mechanisms (9 papers), Bioactive Compounds and Antitumor Agents (5 papers) and DNA Repair Mechanisms (5 papers). Laurent Rigoreau collaborates with scholars based in United Kingdom, New Zealand and China. Laurent Rigoreau's co-authors include Bernard T. Golding, Roger J. Griffin, Graeme C.M. Smith, Ian R. Hardcastle, Caroline J. Richardson, Xiaoling Cockcroft, Niall M.B. Martin, Martin L. Stockley, Mark Frigerio and Keith Menear and has published in prestigious journals such as Journal of the American Chemical Society, The EMBO Journal and PLoS ONE.

In The Last Decade

Laurent Rigoreau

22 papers receiving 1.4k citations

Peers

Countries citing papers authored by Laurent Rigoreau

Since Specialization

Citations

This map shows the geographic impact of Laurent Rigoreau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurent Rigoreau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurent Rigoreau more than expected).

Fields of papers citing papers by Laurent Rigoreau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurent Rigoreau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurent Rigoreau. The network helps show where Laurent Rigoreau may publish in the future.

Co-authorship network of co-authors of Laurent Rigoreau

This figure shows the co-authorship network connecting the top 25 collaborators of Laurent Rigoreau. A scholar is included among the top collaborators of Laurent Rigoreau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurent Rigoreau. Laurent Rigoreau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Structural basis of Fanconi anemia pathway activation by FANCM 2025 ·The EMBO Journal ·Rohan Bythell‐Douglas, Sylvie van Twest, (unknown), Elyse Dunn, (unknown), David C. Briggs, Vincent J. Murphy, (unknown), Winnie Tan, Sarah S. Henrikus, Dongming Qian, (unknown), Jana Wolf, Laurent Rigoreau, Shabih Shakeel, Kathryn Chapman, Neil Q. McDonald, Andrew J. Deans	1
2	Scalable Synthesis of an Acid Stable Analogue of Hippuristanol 2024 ·Organic Letters ·(unknown), Peter Blencowe, Jennifer R. Baker, C. Richard Bennett, Sue E. Boyd, Katherine A. Fowler, Laurent Rigoreau, (unknown), (unknown), Haibin Mao, (unknown), Chengjun Zhao, Fan Zhang, (unknown)	0
3	Morpholylureas are a new class of potent and selective inhibitors of the type 5 17-β-hydroxysteroid dehydrogenase (AKR1C3) 2014 ·Bioorganic & Medicinal Chemistry ·Jack U. Flanagan, Graham J. Atwell, Daniel Heinrich, Darby G. Brooke, Shevan Silva, Laurent Rigoreau, Elisabeth Trivier, A.P. Turnbull, Tony Raynham, Stephen M. F. Jamieson, William A. Denny	32
4	Selective AKR1C3 inhibitors do not recapitulate the anti-leukaemic activities of the pan-AKR1C inhibitor medroxyprogesterone acetate 2014 ·British Journal of Cancer ·Farhat L. Khanim, Nicholas Davies, Pedro Veliça, Rachel Hayden, J.P. Ride, Chathyan Pararasa, Mei Chong, Ulrich L. Günther, Natacha Veerapen, Peter J. Winn, Rohit Farmer, Elisabeth Trivier, Laurent Rigoreau, Mark T. Drayson, Christopher M. Bunce	27
5	Synthesis and structure–activity relationships for 1-(4-(piperidin-1-ylsulfonyl)phenyl)pyrrolidin-2-ones as novel non-carboxylate inhibitors of the aldo-keto reductase enzyme AKR1C3 2013 ·European Journal of Medicinal Chemistry ·Daniel Heinrich, Jack U. Flanagan, Stephen M. F. Jamieson, Shevan Silva, Laurent Rigoreau, Elisabeth Trivier, Tony Raynham, A.P. Turnbull, William A. Denny	30
6	Mechanism-Based Screen for G1/S Checkpoint Activators Identifies a Selective Activator of EIF2AK3/PERK Signalling 2012 ·PLoS ONE ·(unknown), Georgina Platt, S. Elaine Barrie, Georgia Zoumpoulidou, Robert te Poele, G. Wynne Aherne, Stuart C. Wilson, Peter Sheldrake, Edward McDonald, (unknown), Christelle Soudy, Frédéric Elustondo, Laurent Rigoreau, Julian Blagg, Paul Workman, Michelle D. Garrett, Sibylle Mittnacht	86
7	3-(3,4-Dihydroisoquinolin-2(1H)-ylsulfonyl)benzoic Acids: Highly Potent and Selective Inhibitors of the Type 5 17-β-Hydroxysteroid Dehydrogenase AKR1C3 2012 ·Journal of Medicinal Chemistry ·Stephen M. F. Jamieson, Darby G. Brooke, Daniel Heinrich, Graham J. Atwell, Shevan Silva, Emma Hamilton, A.P. Turnbull, Laurent Rigoreau, Elisabeth Trivier, Christelle Soudy, (unknown), Paul Owen, (unknown), Tony Raynham, Jack U. Flanagan, William A. Denny	30
8	Structure-Based Design of Potent and Selective 2-(Quinazolin-2-yl)phenol Inhibitors of Checkpoint Kinase 2 2010 ·Journal of Medicinal Chemistry ·John Caldwell, E. Jane Welsh, (unknown), Victoria E. Anderson, Laurent Antoni, Kathy Boxall, Frederique Urban, Angela Hayes, Florence I. Raynaud, Laurent Rigoreau, Tony Raynham, G. Wynne Aherne, Laurence H. Pearl, Antony W. Oliver, Michelle D. Garrett, Ian Collins	42
9	Improved ATM kinase inhibitor KU-60019 radiosensitizes glioma cells, compromises insulin, AKT and ERK prosurvival signaling, and inhibits migration and invasion 2009 ·Molecular Cancer Therapeutics ·Sarah E. Golding, Elizabeth Rosenberg, Nicholas C.K. Valerie, Isa M. Hussaini, Mark Frigerio, Xiaoling Cockcroft, (unknown), Marc Hummersone, Laurent Rigoreau, Keith Menear, Mark J. O’Connor, Lawrence F. Povirk, Timothy Van Meter, Kristoffer Valerie	285
10	A High‐Content, Cell‐Based Screen Identifies Micropolyin, A New Inhibitor of Microtubule Dynamics 2009 ·Chemical Biology & Drug Design ·Manu De Rycker, Laurent Rigoreau, (unknown), Peter J. Parker	13
11	Identification of potent water-soluble DNA-dependent protein kinase (DNA-PK) inhibitors using a small-molecule library approach [abstract] 2008 ·Cancer Research ·(unknown), Mark R. Albertella, Céline Cano, Nicola J. Curtin, Mark Frigerio, Bernard T. Golding, (unknown), Ian R. Hardcastle, Marc Hummersone, Keith Menear, David R. Newell, (unknown), Caroline J. Richardson, Laurent Rigoreau, (unknown), Graeme C.M. Smith, Roger J. Griffin	3
12	Pyranone, Thiopyranone, and Pyridone Inhibitors of Phosphatidylinositol 3-Kinase Related Kinases. Structure−Activity Relationships for DNA-Dependent Protein Kinase Inhibition, and Identification of the First Potent and Selective Inhibitor of the Ataxia Telangiectasia Mutated Kinase 2007 ·Journal of Medicinal Chemistry ·Jonathan J. Hollick, Laurent Rigoreau, Céline Cano, Xiaoling Cockcroft, Nicola J. Curtin, Mark Frigerio, Bernard T. Golding, (unknown), Ian R. Hardcastle, Ian Hickson, Marc Hummersone, Keith Menear, Niall M.B. Martin, Ian Matthews, David R. Newell, (unknown), Caroline J. Richardson, Graeme C.M. Smith, Roger J. Griffin	61
13	Discovery of Potent Chromen-4-one Inhibitors of the DNA-Dependent Protein Kinase (DNA-PK) Using a Small-Molecule Library Approach 2005 ·Journal of Medicinal Chemistry ·Ian R. Hardcastle, Xiaoling Cockcroft, Nicola J. Curtin, (unknown), (unknown), Martin L. Stockley, Bernard T. Golding, Laurent Rigoreau, Caroline J. Richardson, Graeme C.M. Smith, Roger J. Griffin	137
14	Identification of a Highly Potent and Selective DNA‐Dependent Protein Kinase (DNA‐PK) Inhibitor (NU7441) by Screening of Chromenone Libraries. 2005 ·ChemInform ·(unknown), Bernard T. Golding, Roger J. Griffin, Ian R. Hardcastle, Caroline J. Richardson, Laurent Rigoreau, Graeme C.M. Smith	2
15	Identification of a highly potent and selective DNA-dependent protein kinase (DNA-PK) inhibitor (NU7441) by screening of chromenone libraries 2004 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Bernard T. Golding, Roger J. Griffin, Ian R. Hardcastle, Caroline J. Richardson, Laurent Rigoreau, Graeme C.M. Smith	319
16	Selective Benzopyranone and Pyrimido[2,1-a]isoquinolin-4-one Inhibitors of DNA-Dependent Protein Kinase: Synthesis, Structure−Activity Studies, and Radiosensitization of a Human Tumor Cell Line in Vitro 2004 ·Journal of Medicinal Chemistry ·Roger J. Griffin, Gabriele Fontana, Bernard T. Golding, (unknown), Ian R. Hardcastle, (unknown), Niall M.B. Martin, Caroline J. Richardson, Laurent Rigoreau, Martin L. Stockley, Graeme C.M. Smith	126
17	2,6-Disubstituted pyran-4-one and thiopyran-4-one inhibitors of DNA-Dependent protein kinase (DNA-PK) 2003 ·Bioorganic & Medicinal Chemistry Letters ·Jonathan J. Hollick, Bernard T. Golding, Ian R. Hardcastle, Niall M.B. Martin, Caroline J. Richardson, Laurent Rigoreau, Graeme C.M. Smith, Roger J. Griffin	83
18	Synthesis, crystal structure determination, and biological properties of the DNA-dependent protein kinase (DNA-PK) inhibitor 3-cyano-6-hydrazonomethyl-5-(4-pyridyl)pyrid-[1H]-2-one (OK-1035) 2001 ·Bioorganic & Medicinal Chemistry Letters ·Martin L. Stockley, W. Clegg, Gabriele Fontana, Bernard T. Golding, Niall M.B. Martin, Laurent Rigoreau, Graeme C.M. Smith, Roger J. Griffin	24
19	Reactivity and Mechanism in the Hydrolysis of β-Sultams 2000 ·Journal of the American Chemical Society ·(unknown), Laurent Rigoreau, Andrew P. Laws, Michael I. Page	76
20	The hydrolytic reactivity of β-sultams 1996 ·Journal of the Chemical Society Perkin Transactions 2 ·(unknown), Andrew P. Laws, Laurent Rigoreau, Michael I. Page	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact